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Abstract
Strengthening current surveillance systems for syphilis is important to track and monitor disease 
burden. We used routinely collected laboratory information to generate surveillance estimates for 
syphilis trends among women of reproductive age (12–49 years) in the Northern Cape Province, a 
high syphilis burden region (2003 [8.6%] to 2011 [3.8%]) in South Africa. We extracted records 
meeting inclusion criteria from the National Health Laboratory Service electronic database for the 
period 2003–2012. A total of 286,024 women were included in the analysis. Syphilis 
seropositivity decreased between 2003 (5.7%) and 2012 (1.8%); p trend = 0.001, which was 
largely consistent with findings reported in the annual national syphilis and HIV survey from 2003 
(8.6%) to 2011 (3.8%). Annually for the period from 2003 to 2012 there was an approximate 14% 
reduction in the prevalence ratio of syphilis seroprevalence (PR = 0.86, 95% CI = 0.85–0.87, p 
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<0.001). Three of five districts had significant decreases in syphilis seropositivity over this period. 
There were also declines in prevalence ratios for syphilis seropositivity for the various age groups 
for the period. This study shows that the national laboratory database in South Africa can be used 
as a complimentary surveillance tool to describe and understand trends in syphilis seroprevalence 
in South Africa.
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Introduction
Syphilis is a sexually transmitted infection (STI) and continues to be a major preventable 
global public health problem, with an estimated 12 million people infected each year.1 
Syphilis continues to affect large numbers of pregnant women, causing substantial perinatal 
morbidity and mortality that could be prevented by early testing and treatment. Screening 
pregnant women for syphilis during routine antenatal care and then treating any detected 
infections with penicillin injections has been feasible for many years, even in low-resource 
settings.1 However, because coverage of testing and treatment of syphilis remains low in 
many countries, mother-to-child transmission (MTCT) of syphilis, commonly referred to as 
‘congenital syphilis’ (CS) is still a global public health problem.2 National guidelines in 
South Africa have recommended universal syphilis testing for ANC attendees since 2002.3 
In South Africa, three doses of benzathine penicillin 2.4 MU at weekly intervals are 
recommended for treating syphilis in pregnancy. However, limited information is available 
on compliance with the recommended regimen, in terms of starting treatment, number of 
doses, and timing of treatment. Pregnant women who are allergic to penicillin may be given 
alternative therapy with a two-week course of erythromycin.4 A study in two provinces 
(Northern Cape and Gauteng) in South Africa found that although 71% of pregnant women 
were tested for syphilis at first ANC visit, only 74% of women who tested positive for 
syphilis had treatment documented, and only 36% of seropositive women with documented 
treatment received the recommended three doses of intramuscular penicillin.5
In 2008, approximately 1.4 million pregnant women worldwide were estimated to have 
probable active syphilis infection and were at risk of transmitting the disease perinatally to 
their unborn children; of those, 80% had attended ANC.2 Worldwide, 520,000 adverse 
outcomes were estimated to be caused by maternal syphilis in 2008, including 215,000 
stillbirths (>28 wk) or early foetal deaths (22 to 28 wk), 90,000 neonatal deaths, 65,000 
preterm or low birth weight infants, and 150,000 infants with congenital disease. About 66% 
of these adverse effects occurred in ANC attendees who were not tested or were not treated 
for syphilis. Finally, in 2008, clinical services averted an estimated 26% of all adverse 
outcomes.2 In developing countries, approximately 3–15% of women of child-bearing age 
have syphilis, and about 30% of pregnant women with syphilis will have stillbirth, and 
another 30% will have a live baby with CS, a condition with mortality of up to 50%.6 CS 
results in deaths of more than one million babies a year worldwide.6
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In 2007, the World Health Organization (WHO) launched its initiative for the Global 
Elimination of Congenital Syphilis, with the goal that at least 90% of pregnant women be 
tested for syphilis and at least 90% of seropositive pregnant women receive adequate 
treatment by 2015.1,7 In line with this global aim to eliminate CS as a public health problem, 
it is important to strengthen existing surveillance systems for syphilis in order to track and 
monitor disease burden. In South Africa, unlinked anonymous surveys in sentinel antenatal 
clinics have been conducted annually since 1990 to monitor syphilis seroprevalence among 
pregnant women. It is important to explore a complementary approach to understanding the 
syphilis burden in South Africa by utilizing routinely collected electronic laboratory data for 
surveillance, which provides efficient access to data, and has large-scale coverage. The 
Northern Cape Province is a region with high syphilis burden compared with other provinces 
in South Africa,8 see Figure 1. We set to determine whether the national electronic 
laboratory data repository also known as the Corporate Data Warehouse (CDW) can be 
employed as appropriate complimentary surveillance data source to track and monitor trends 
in syphilis seroprevalence in South Africa. Specifically, this paper describes trends in 
syphilis seroprevalence in women of reproductive age in Northern Cape Province, South 
Africa, between 2003 and 2012, using laboratory data routinely collected through South 
Africa’s National Health Laboratory Service (NHLS) CDW and compares the computed 
trends with findings from the National Antenatal Sentinel HIV & Syphilis Prevalence 
Surveys during the same period.
Methods
Study design and setting
We analysed secondary data of longitudinally collected laboratory measurements from the 
CDW. The Northern Cape Province is a large and sparsely populated region in the west of 
South Africa, with an estimated population of 1.1 million.9 It is a high-burden syphilis 
region. It is administratively divided into five District Municipalities: Frances Baard, John 
Taolo Gaetsewe, Namakwa, Pixley Ka Seme, and Siyanda. Data from the public sector 
health facilities of the Northern Cape Province, where syphilis serology tests are conducted, 
were utilized in this study.
Study population
As the study objective was to explore if the analysis of electronic laboratory data from the 
CDW could estimate the trends from the National Antenatal Sentinel HIV & Syphilis 
Prevalence survey conducted annually in South Africa, we selected from the database 
females of reproductive age (12–49 years) identified from the Northern Cape Province. 
Other criteria for inclusion in the study were having tested for syphilis by serology between 
2003 and 2012 (positive Rapid Plasma Reagin [RPR] confirmed by Treponema pallidum 
hemagglutination assay [TPHA]). The reasons for testing the women whose tests results 
ended up in the CDW were: (1) routine antenatal screening (the majority of syphilis tests are 
done routinely during ANC visits) and (2) when indicated for sexual assault, suspected 
secondary syphilis, suspected tertiary syphilis, and 6-month follow-up of early syphilis cases 
treated with doxycycline.10
Ballah et al. Page 3













Data sources and variables
The NHLS has a national network of 265 laboratories. Results of all tests performed in 
NHLS laboratories in the public sector health facilities in South Africa are sent to a central 
repository, the CDW, which contains archived test data from the countrywide laboratory 
information system. Each laboratory test data is captured onto an in-house laboratory 
information system which electronically feeds centrally to the CDW and are available for 
analysis in real time. The quality of the data in the CDW depends on accurate completion of 
the laboratory requisition form and data capturing.11 Whilst some tests may not be reported, 
this is not very common. Data for this study were obtained from the CDW between 2003 and 
2012. Variables captured onto this electronic database include patient-identifying 
information, demographic information, name of health facility where test was performed, 
tests requested, date of test, and test result.
Laboratory testing
The syphilis serologic tests performed include the non-treponemal test (RPR) and 
treponemal test (TPHA). Blood specimens are collected by each public health facility 
(clinic) and sent to the nearest NHLS laboratory for testing. Women do not have to travel to 
access laboratories, there is easy clinic access. Though RPR measures disease activity, it is 
not specific for syphilis. The RPR test can distinguish between an active infection and a past 
infection.10 False RPR-positive reactions may occur, notably in patients with connective 
tissue disorders (false positive reactions are usually low titre <1:8). It is government/
National Department of Health policy that the standard algorithm (RPR/TPHA) is used in 
every test. A non-treponemal test, RPR, is used for screening. If non-reactive then the result 
is deemed negative for syphilis; however, if positive, TPHA is done and if reactive – result is 
positive for syphilis.10,12
Statistical methods
As a unique identifier is not available in the CDW, identification fields were used together 
and a probabilistic record linkage technique was applied. In probabilistic record linkage, 
personal identifiers (e.g. name, sex, date of birth, area of residence) are used together in 
order to determine how likely a pair of records refers to the same individual. We extracted a 
total of 8,471,425 syphilis tests, covering the entire country, for the period 2003–2012. We 
limited analysis to the Northern Cape Province, which had a total of 310,730 tests meeting 
the inclusion criteria. The rationale of limiting the data to the Northern Cape region is that in 
South Africa while overall the prevalence of syphilis seropositivity among antenatal clinics 
attendees has decreased over the past 10–15 years, the Northern Cape Province has 
consistently showed a higher syphilis prevalence for each year from 2003 to 2011 than any 
other province, except for Western Cape Province in 2007 (5.6%) and Mpumalanga Province 
in 2011 (4.1%).8 So this region is currently the priority region in terms of strengthening 
syphilis surveillance in South Africa. This dataset was then de-duplicated resulting in a final 
number of 286,024. These were de-duplicated in order to have one single syphilis test record 
per person, i.e. the same testing episode may have been captured more than once on the 
database or a person may have had more than one syphilis testing episode within a year. If a 
person had more than one syphilis diagnostic testing episode during the year e.g. tested in 
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January and then tested in August of the same year, the last record was retained in order to 
have one person record within a single year.
We used frequencies, proportions, and the Chi square test for trend to examine the changes 
in syphilis seroprevalence from 2003 to 2012. We applied the modified-Poisson regression 
approach (with robust error variance) to estimate prevalence ratios (PR) and 95% CIs of 
syphilis seroprevalence over time. Syphilis seroprevalence was the dependent variable and 
calendar year was the main independent variable controlling for age and geographical 
location. Separate analyses by age group and geographical location were also performed. We 
used the simple linear regression analysis of differences in annual prevalences over time to 
test for the significance of the difference in trend between the NHLS data and the antenatal 
survey data. We found no significant differences between the slopes of CDW and ANSUR 
prevalences (slope = −0.013, 95% CI: −0.277 to 0.250, p = 0.982). All analyses were 
conducted in STATA version 13 (Stata Corp., College Station, TX, US).
Ethical clearance
Permission to analyse the laboratory data was obtained from the NHLS. Ethical clearance to 
conduct the study was obtained from the Faculty of Health Sciences Research Ethics 
Committee of the University of Pretoria. We ensured that the dataset was secured and kept 
confidential by separating patient-identifying details from the laboratory data and storing the 
master list that links patient-identifying details to study patient identifiers in a separate, 
secured location. The dataset was password-protected and was only accessible to the three 
supervisors and the investigator.
Results
A total number of 286,024 women were included in the study after applying the inclusion 
criteria and de-duplication. Table 1 shows the characteristics of the study population per year 
from 2003 to 2012. The mean (standard deviation [SD]) age ranged from 25.7 (6.9) years in 
2003 to 27.9 (8.1) years in 2012. The majority of women were in the 26–49 years age group 
(45.4% in 2003 to 55.4% in 2012).
There was an overall decline in syphilis seroprevalence between 2003 (5.7%) and 2012 
(1.8%); p trend: 0.001. This decline was consistent with findings published from the 
National Antenatal Sentinel HIV & Syphilis Prevalence Surveys from 2003 (8.6%) to 2011 
(3.8%),8 as shown in Table 2. Annually for the period from 2003 to 2012 there was an 
approximate 14% reduction in the prevalence ratio of syphilis seroprevalence (PR = 0.86, 
95% CI = 0.85–0.87, p <0.001).
Decline in syphilis seroprevalence was also seen across all age groups from 2003 to 2012: 
12–17 years (4.2% to 2.2%), 18–25 years (5.7% to 1.8%), and 26–49 years (5.9% to 1.7%), 
p trend = 0.001. There was heterogeneity in changes of syphilis seroprevalence over time by 
geographical location/region in the Northern Cape Province. Three out of five districts, 
Frances Baard (6.9% to 0.9%), John Taolo Gaetsewe (7.4% to 0.7%), and Namakwa district 
(3.3% to 1.7%) experienced significant decreases in syphilis seroprevalence over the 10-year 
period. Pixley Ka Seme district had an increase in syphilis seroprevalence from 2003 to 
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2004 (5.4% to 6.4%); largely similar from 2004 to 2008 (6.4%, 6.1%, 7.0%, 6.3%, 6.5%); 
experienced a decrease from 2008 to 2011 (6.5% to 4.3%), and another increase from 2011 
to 2012 (4.3% to 6.9%). Siyanda district had an increase from 2003 to 2004 (4.2% to 9.0%) 
and decrease from 2004 to 2012 (9.0% to 4.1%). Table 3 below illustrates the overall 
syphilis seroprevalence by year, age group, and geographic location (districts). A similar 
pattern to that of the prevalence was reflected when the prevalence ratios were computed and 
this decrease was statistically significant across all age groups and geographic location (p 
trend: <0.001). See Tables 4 and 5.
Discussion
This study explored the utility of routinely collected laboratory information in the Northern 
Cape Province, South Africa, as a supplemental source of surveillance data to monitor 
syphilis trends among women of reproductive age. Overall, syphilis seroprevalence showed 
statistically significant decreases between 2003 and 2012. Our estimates are largely 
consistent with previously published data from the National Antenatal Sentinel HIV & 
Syphilis Prevalence Survey from 2003 to 2011.8 Although three of the five districts of the 
Northern Cape Province had statistically significant decreases in syphilis seroprevalence, 
there were variations in trend pattern among the other two districts over the 10-year period. 
The key strength of our study is that it demonstrated that routinely collected electronic 
laboratory data can accurately portray the trends in the prevalence of syphilis in South 
Africa. The implications of our study findings are that laboratory-based estimates of the 
burden of disease at national and provincial levels serve as a useful tool in surveillance. 
Laboratory data can be a good indicator of trend, while understanding that it may not be as 
representative of the population. For over two decades, conventional methods of surveillance 
(ANC prevalence surveys), which have been largely paper-based records, have been used to 
monitor trends in syphilis seropositivity in South Africa.13
The Northern Cape Province is a region of high syphilis burden compared with other 
provinces in South Africa, with syphilis seroprevalence for each year from 2003 to 2011 
being higher than any other province, except for Western Cape Province in 2007 (5.6%) and 
Mpumalanga Province in 2011 (4.1%).8 Our data showed that syphilis seroprevalence in the 
Northern Cape Province has decreased significantly over the study period. Other South 
African studies have also suggested declines in Syphilis seroprevalence in the Northern Cape 
Province.5,8,14 As other studies have shown, this decrease may be attributable to a number of 
factors such as the implementation of syndromic management of STIs in most limited 
resource settings, improved access to healthcare and widespread use of antibiotics, reduction 
in risky sexual behaviours in a population, and mortality due to HIV/AIDS.15,16 A South 
African study suggests that increased condom use, improved treatment of STIs, and 
mortality due to HIV/AIDS collectively led to significant reduction in syphilis prevalence 
between 1990 and 2005.17 Improved ANC visits (more women attending ANC for first visit 
with better services) and increased awareness and health education of women and girls about 
the consequences of syphilis by healthcare providers during ANC visits are factors that also 
contribute to the downward trend in the prevalence of syphilis in pregnant women.15,17 The 
WHO recommends a minimum of four ANC visits, starting in the first 12 weeks of 
pregnancy.18 ANC is provided free of charge in the South African public health system and 
Ballah et al. Page 6













nearly all pregnant women and girls attend ANC at least once during their pregnancy 
(between 90 to 100% of pregnant women attend a health facility at least once for ANC).19
The highest decrease in syphilis seroprevalence for the period among the various age groups 
was recorded in the 26–49 years (15%), followed by the 18–25 years (13%), and then 12–17 
years (10%) age groups. Future trends in syphilis seroprevalence in the overall population 
may be predicted by trends in the youngest pregnant women, as syphilis infection in the 12–
17 years age group (4.2% [2003] to 2.2% [2012]) are likely to be more recent and may best 
reflect incidence of disease.20 Though Pixley Ka Seme and Siyanda districts showed 
variations in terms of decreases there was, however, an overall marginal decrease. Pixley Ka 
Seme district falls in the second socio-economic quintile (out of five quintiles, the first 
quintile is the most deprived and the fifth quintile is the least deprived), among the poorer 
districts, whereas Siyanda district falls in the third socioeconomic quintile. John Taolo 
Gaetsewe, Namakwa, and Frances Baard districts fall in the fourth socioeconomic quintile, 
among the wealthier districts.21 Findings from studies in Malawi, Tanzania, and Zambia 
suggest that syphilis seroprevalence rates are highest among people in areas with high 
crowding and high levels of economic deprivation, as measured by poverty, and that there is 
positive association with lower syphilis prevalence among higher socio-economic status and 
education.22 These findings are likely to apply to South Africa.
The findings of this study should be interpreted with caution in light of several limitations. 
First, all the tests from the National Antenatal Sentinel HIV & Syphilis Prevalence Survey 
end up in the CDW (there is partially a comparison of the same tests). However, numbers 
from the survey represent <5% of the total female population that had syphilis tests, i.e. for 
2011. For 2011, the antenatal survey had a sample size of 1128 for the Northern Cape 
Province and the CDW had a sample size of 35,175 for the Northern Cape Province, 
representing 3.2% (1 128/35 175). Second, this is a secondary dataset analysis and the CDW 
dataset is limited by the variables that are stored and quality of the data, which depend on 
accurate completion of the laboratory requisition form and data capturing. Since record 
linkage techniques were used, only records with complete information and therefore better 
chance of linkage are included in the study, leading to potential selection bias. Also, the 
linkage may not have been good enough in truly identifying unique people, thus resulting in 
multiple records for the same individual going unmatched or mismatched records that reduce 
the number of real individuals. Third, since the de-duplication approach retains the last 
testing episode done in order to achieve a single record per person within that year, this 
could underestimate the actual syphilis prevalence. Where follow-up testing of early syphilis 
was not confirmed with TPHA, there will be an initial true positive result with a negative 
follow-up test, thus resulting in a negative result being retained. Fourth, we only used one of 
the nine provinces of South Africa to compare with available data, which makes our sample 
not representative and findings not generalizable to South Africa as a whole. Finally, 
participants of the study included only women who attended public health facilities, leaving 
out those who attended private health facilities and those who do not access health services, 
also leading to potential overestimation of the syphilis burden. Our study aim was to 
compare the estimates from the electronic laboratory data with those of the National 
Antenatal Sentinel HIV & Syphilis Prevalence Survey. Though the objective of determining 
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the utility of the electronic laboratory data may have been achieved, we may have 
overestimated the burden of syphilis in Northern Cape Province.
Conclusions
There was significant decline in syphilis seroprevalence in the Northern Cape Province, 
which was largely consistent with findings from the National Antenatal Sentinel HIV & 
Syphilis Prevalence Surveys. We have shown that a national electronic laboratory database 
with high coverage can be used to assess trends in syphilis seropositivity in South Africa. 
This highlights that completeness and quality of routine electronic laboratory data should be 
strengthened in order to enhance the quality of this simple, inexpensive disease surveillance 
approach.
Acknowledgments
We gratefully recognize the invaluable role played by the hardworking staff of the Centre for HIV and Sexually 
Transmitted Infections (STI section) of the National Institute for Communicable Diseases (NICD), particularly the 
guidance and expertise of Prof. David A. Lewis (Former Head) in conceiving this project. We also sincerely 
appreciate the enormous contributions of the South African Field Epidemiology Training Programme (SA FETP), 
particularly Drs Carl Reddy and Patience Kweza. We also thank Ms Dorothy Southern of the US Centers for 
Disease Control and Prevention, South Africa, for editing the manuscript.
Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of 
this article: This research has been supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) 
through the Centers for Diseases Control and Prevention under the terms of 5U2GPS001328-05.
References
1. The global elimination of congenital syphilis: rationale and strategy for action. Geneva: World 
Health Organization; 2007. http://www.who.int/reproductivehealth/publications/rtis/
9789241595858/index.htmi [accessed 25 June 2015]
2. Newman L, Kamb M, Hawkes S, et al. Global estimates of syphilis in pregnancy and associated 
adverse outcomes: analysis of multinational antenatal surveillance data. Plos Med. 2013; 
10:e1001396. [PubMed: 23468598] 
3. Department of Health Guidelines for Maternity Care in South Africa. [accessed 10 November 2015] 
A Manual for Clinics, Community Health Centres and District Hospitals. 22002. http://
healthweb.kznhealth.gov.za/maternityguidelines.pdf
4. Mullick, S., Beksinksa, M., Msomi, S. [accessed 20 September 2013] Treatment for syphilis in 
antenatal care: compliance with the three dose standard regimen. http://www.sti.bmjjournals.com
5. Dinh, TH., Lewis, D., Trege, L., et al. Prevalence of and adherence to HIV prophylaxis and syphilis 
treatment regimenin pregnant women receiving antenatal care services in public facilities in 
Northern Cape and Gauteng Provinces, South Africa, 2004–2006. [Poster Presentation]. HIV/AIDS 
Implementers’ Meeting; 3–7 June 2008; Kampala, Uganda. 
6. The use of rapid syphilis tests. The sexually transmitted diseases diagnostic Initiative/World Health 
Organization, 2006.
7. Kamb ML, Newman Lori M, Riley PL, et al. A road map for global elimination of congenital 
syphilis. Obstet Gynecol Int. 2010; 2010:312798. [PubMed: 20706693] 
8. National Department of Health SA. The 2011 National Antenatal Sentinel HIV and Syphilis 
Prevalence Survey in South Africa. National Department of Health; South Africa: 2012. 
9. Census 2011: Census in brief. Statistics South Africa; Pretoria: 2012. 
10. Sexually Transmitted Infections Management Guidelines. Adapted from: Standard Treatment 
Guidelines and Essential Drug List PHC. National Department of Health; South Africa: 2015. 
Ballah et al. Page 8













11. Sherman GG, Lilian R, Bhardwa S, et al. Laboratory information system data demonstrate 
successful implementation of the mother-to-child transmission programme in South Africa. South 
African Med J. 2014; 104:235–238.
12. Centers for Disease Control and Prevention. Sexually transmitted infection disease surveillance, 
2012. Atlanta, GA: US Department of Human Services; 2014. 
13. Goga, AE., Dinh, T., Jackson, DJ. for the SAPMTCTE study group. Evaluation of the 
Effectiveness of the National Prevention of Mother-To-Child Transmission (PMTCT) Programme 
Measured at Six Weeks Postpartum in South Africa, 2010. South African Medical Research 
Council, National Department of Health of South Africa and PEPFAR/US Centers for Disease 
Control and Prevention; 2012. 
14. Dihn TH, Kamb M, Msimang V, et al. Integration of preventing mother-to-child transmission of 
HIV and syphilis testing and treatment in antenatal catre services in the Northern Cape and 
Gauteng Provinces, South Africa. Sex Transmitted Dis. 2013; 40:846–851.
15. Creek TL, Thuku H, Kolou B, et al. Declining syphilis prevalence in pregnant women in northern 
Botswana: an encouraging sign for HIV prevention? Sex Transm Infect. 2005; 81:453–455. 
[PubMed: 16326844] 
16. Temmerman M, Fonck K, Bashir F, et al. Declining syphilis prevalence in pregnant women in 
Nairobi since 1995: another sucess story in the STD field? Int J STD AIDS. 1999; 10:405–408. 
[PubMed: 10414884] 
17. Johnson LF, Dorrington R, Bradshaw D, et al. The effect of syndromic management interventions 
on the prevalence of sexually transmitted infections in South Africa. Sex Reprod Health. 2011; 
2:13–20.
18. Abou-Zahr, CH., Wardlaw, TM. Analysis of trends, levels and differentials, 1990–2001. Geneva: 
World Health Organization; 2003. Antenatal care in developing countries: promises, achievements 
and missed opportunities. 
19. National Department of Health, Medical Research Council. South African Demographic and 
Health Survey 2003. Pretoria: 2007. 
20. Podgor M, Leske C. Estimating incidence from age-specific prevalence for irreversible disease 
with differential mortality. Stats Med. 1986; 5:573–758.
21. Massyn, N., Day, C., Peer, N., et al. District Health Barometer 2013/14. Durban: Health Systems 
Trust; 2014. 
22. Potter D, Goldenberg R, Read JS, et al. Correlates of syphilis seropositivity among pregnant 
women: The HIVNET 024 Trial in Malawi, Tanzania and Zambia. Sex Transm Dis. 2006; 33:604–
609. [PubMed: 16601659] 
Ballah et al. Page 9














Map of South Africa and the Northern Cape Province showing all the districts along with 
province boundary. (Source: www.mapsofworld.com)
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